STAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programs

WASHINGTON — President Trump made an announcement Friday to tout one of his initiatives to lower drug prices. It left many questions unanswered. All 50 states, Washington, D.C., and Puerto Rico will participate in the GENEROUS model, which is intended to give lower drug prices to Medicaid programs, Trump said. As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under GENEROUS. The deals are a major component of President Trump’s plan to lower drug prices, and have become key to his messaging on affordability. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe